Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)-China Extension
ClinicalTrials.gov study NCT04907227. IPD Sharing: YES. Countries: 1. Publications: 0.
GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer
ClinicalTrials.gov study NCT01420861. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
ClinicalTrials.gov study NCT01313273. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT03503344. IPD Sharing: NO. Countries: 1. Publications: 0.
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
ClinicalTrials.gov study NCT07198724. IPD Sharing: YES. Countries: 1. Publications: 0.
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
ClinicalTrials.gov study NCT07214779. IPD Sharing: YES. Countries: 14. Publications: 0.
A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer
ClinicalTrials.gov study NCT00992186. IPD Sharing: Not stated. Countries: 4. Publications: 0.
GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT02012192. IPD Sharing: Not stated. Countries: 4. Publications: 0.
TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02764333. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT00408603. IPD Sharing: YES. Countries: 2. Publications: 0.
Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01540071. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors
ClinicalTrials.gov study NCT03781778. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases
ClinicalTrials.gov study NCT01834651. IPD Sharing: NO. Countries: 1. Publications: 0.
Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer
ClinicalTrials.gov study NCT01650350. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Su
ClinicalTrials.gov study NCT02097303. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate Cancer
ClinicalTrials.gov study NCT03690141. IPD Sharing: NO. Countries: 1. Publications: 0.
Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT01853644. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT05968599. IPD Sharing: NO. Countries: 1. Publications: 0.
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
ClinicalTrials.gov study NCT05535192. IPD Sharing: YES. Countries: 1. Publications: 0.
ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT03300505. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.